Probiotics Help in Congenital Heart Disease

The oral administration of probiotic products to infants with cyanotic congenital heart disease was associated with improved outcomes, including better survival, a Turkish randomized study found.

Among 100 infants given Bifidobacterium lactis plus inulin or placebo, 8% of the active treatment group developed sepsis compared with 28% of the placebo group (P=0.01), according to Dilek Dill...

Posted by John Rintamaki on Wednesday, September 18, 2013